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CareCloud, a privately held technology com-
pany headquartered out of Miami, states that accord-
ing to recent figures, the average cost of an organ 
transplant in the U.S. can reach well over $1 mil-
lion. Furthermore, according to the United Network 
for Organ Sharing (UNOS), more than 113,000 pa-
tients in the U.S. are currently waiting for an organ 
transplant. Anne Paschke of UNOS stresses this need 
for organs by expressing that only 1 to 2 percent of 
the population dies in a way that 
makes them potential organ donors. 
Although the need for organs has yet 
to be met, bioprinting has the poten-
tial of saving lives by addressing this 
chronic shortage through various ap-
plications. 
Many of you may have heard 
of 3-D printing, but have you heard 
of bioprinting? Bioprinting is a bio-
technology that does not fail to excite 
optimists in the biotech industry. 
Specifically, bioprinting is “an addi-
tive manufacturing process where 
biomaterials such as hydrogels or 
other polymers are combined with cells and growth 
factors, and then printed to create tissue-like struc-
tures that imitate natural tissues” (What). You may be 
wondering how exactly this printing process takes 
place. Futurity explains that bioprinting involves us-
ing a computer-guided pipette that takes up cell cul-
tures and “prints” them out in gel layers onto biopa-
per. This biopaper degrades over time; leaving be-
hind the printed structure. According to the Australi-
an Academy of Science (AAS), every tissue in the 
body is naturally made up of different cell types, so 
the required cells are taken from a patient and culti-
vated until there are enough to create cell specific 
‘bio-ink’ that is loaded into the printer. Moreover, the 
AAS explains how these cells seek out similar cells 
to join with much like the way cells in an embryo de-
velop in the womb during embryogenesis, or tissue in 
an adult moves to repair damage. Because the parts 
are synthesized from the organ recipient’s genetic 
matter and precisely match the tissue or organ being 
replaced, CareCloud states that there is less of a 
chance that the immune system will reject the foreign 
tissue. Now that we have covered the basics of sourc-
ing, growing, and implanting bio-prints, let’s talk 
about bioprinting’s potential applications. 
From patient-specific surgical models and 
personalized medicines to replacement body parts 
and custom-made prosthetics, the possibilities of bi-
oprinting are endless. A serious car accident that re-
sults in a passenger’s nose being shattered serves as a 
great example of a situation in which bioprinting can 
be put to use. According to the AAS, bi-
oprinting technology makes it possible to 
reconstruct this nose as a 3D model on the 
computer. A biopsy can simultaneously be 
performed on the patient while cartilage 
cells are extracted from the knee, finger, 
ear or splinters of the shattered nose. The 
cells are reproduced in the laboratory and 
mixed with a biopolymer, which is then 
used to print a new nose to be implanted 
during surgery. In this process, the biopol-
ymer is used as a form of shaping mold 
that is gradually broken down by the body 
and replaced by its own cells. This re-
placement leaves the implant unrecogniza-
ble as it appears cohesive with the individual’s own 
skin and cartilage. Moreover, Futurity forecasts that 
mass-supplied prosthetics are likely to be a thing of 
the past as 3D printing is increasingly used to manu-
facture prosthetics that are tailored to a patient’s anat-
omy and needs. For example, Futurity explains that 
surgeons have to cut a patient’s bone to fit the pros-
thetic in a hip-replacement, but in the future, it will 
be normal to 3D print a prosthetic to fit a patient. Ad-
ditionally, bioprinting has extensive applications in 
the pharmaceutical industry with the potential to 
drastically reduce the need for animal trials in drug 
testing. Cellink contends that this technology offers 
the potential to test treatments for diseases using arti-
ficially affected tissues, eradicating organ donation 
and transplantation. Perhaps bioprinting’s most sig-
nificant application is the use of 3D printed models to 
practice surgical operations. According to Jason 
Chuen, Director of Vascular Surgery at Austin Health 
and a Clinical Fellow at the University of Melbourne, 
studies have shown that operations can be completed 
faster and with less trauma for patients and the poten-
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tial cost savings alone are considerable. Although 
these ideas sound both exciting and feasible, profes-
sionals have a long way to go until these applications 
become reality.  
Aside from potential applications of bioprint-
ing in the medical field, professionals are currently 
making progress in the development of bioprinting as 
it pertains to some similar applications. “In 2003, 
Wake Forest succeeded in printing the first fully func-
tional mini-kidney, which was able to filter blood and 
produce urine. Since then, scientists have been work-
ing to develop more sophisticated organs like hearts, 
livers and uteruses” (Carecloud). Chuen explains that 
once inside the gel, cells can die in a matter of 
minutes. This isn’t a problem for small structures like 
organoids, an artificially grown organ, that can be 
built quickly and then transferred back into a nutrient 
solution, but it is a problem when attempting to print 
an organ because the initial layers of cells will die be-
fore the organ is completed. Dave Fornell of Diagnos-
tic and Interventional Cardiology argues that the 
Achilles heel of tissue engineering today is the need 
to create vascularity in the structure. He states that the 
key to printing vascularizable micro-organs involves 
chemical modifications of alginate hydrogels to pro-
mote organoid vascularity and suppress inflammatory 
responses. According to Fornell, what we can print 
right now are cardiac patches and small- to medium-
sized blood vessels, skin tissue, soft tissue for recon-
structive surgery, and vascularized micro-organs that 
can be grown in a bioreactor and used to supplement 
the function of a diseased organ like the liver. 
Recent breakthroughs in bioprinting include a 
team from Swansea University’s work that 
has developed a bioprinting process that can create an 
artificial bone matrix in the exact shape of the bone 
required. Mischa explains that, “Over a period of sev-
eral months, the implants fuse with and are eventually 
replaced by a patient’s natural bones with few, if any, 
complications.” The AAS recognizes similar work at 
Wake Forest School of Medicine where researchers 
have successfully designed, built and tested a printer 
that can print skin cells directly onto a burn wound. 
Research engineer Monica Moya from Lawrence Liv-
ermore National Laboratory is also using bioprinting. 
The AAS explains how Moya is using the technology 
to create ‘living’ blood vessels by enabling small 
blood vessels to develop on their own. “Over a period 
of time, the self-assembled capillaries connect with 
the bio-printed tubes, thereby beginning to deliver 
nutrients to the cells on their own—mimicking the 
way these structures work in the human 
body” (science.org). Dr. Anthony Atala, director of 
the Wake Forest Institute for Regenerative Medicine, 
predicts that someday, perhaps in the span of a gener-
ation, you can have a heart made out of your own cell 
tissue. The biotechnology industry is growing at an 
unprecedented rate and the prospects of bioprinting 
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